Idiopathic short stature (ISS) remains one of the most frequent and challenging diagnoses in pediatrics. It is defined as a significantly shorter height than expected for age and sex, without any identifiable cause. This makes ISS a diagnosis of exclusion, encompassing multiple underlying conditions. Responses to growth hormone treatment are variable, reflecting this heterogeneity.

Today, new tools are transforming the landscape. Advances in genetics—especially next generation sequencing (NGS)—together with applications of artificial intelligence, are improving diagnostic accuracy and guiding more personalized care. These advances help clinicians determine which children truly benefit from genetic testing and tailored therapeutic approaches.

To bring these innovations closer to the medical community, the Latin American Society for Pediatric Endocrinology (SLEP) is hosting the webinar “Growth disorder care: practical solutions for investigating and treating ISS, and the contribution of genetic studies” on October 24, 2025, from 14:00 to 15:00 CEST (06:00 Mexico City, 09:00 Argentina).

The event will feature distinguished international experts: Richard J.M. Ross (University of Sheffield, UK), Helen Storr (Queen Mary University of London, UK), and Martin O. Savage (Barts and the London School of Medicine and Dentistry, QMUL, UK).

It will be a valuable opportunity for pediatricians, endocrinologists, and healthcare professionals to learn the latest evidence, discover practical criteria to recognize ISS, and integrate clinical expertise with AI and genetics to improve patient outcomes.

👉 Free access with prior registration. Reserve your spot here.